{"01": {"patient_info": {"profile": {"condition": "Amyotrophic Lateral Sclerosis", "country": "France", "age": 53, "gender": "Male", "profile": "Histology: None\nPrevious treatment: riluzole since two months\nBiomarkers: SOD1 mutation\nTests: None\nComorbidities: rheumatoid arthritis\nOther: None"}}, "trial_matches": [{"nct_id": "NCT06114056", "eligibility": "ineligible", "reasoning": "Patient is a 53-year-old male with Amyotrophic Lateral Sclerosis, not a male child aged 5 to 10 years with Duchenne Muscular Dystrophy as required by the trial criteria."}, {"nct_id": "NCT06224660", "eligibility": "ineligible", "reasoning": "Patient has ALS, not Duchenne Muscular Dystrophy or cardiomyopathy; does not meet disease-specific inclusion criteria."}, {"nct_id": "NCT03340675", "eligibility": "ineligible", "reasoning": "The trial is for subjects with Duchenne Muscular Dystrophy (DMD), but the patient has Amyotrophic Lateral Sclerosis (ALS), which does not meet the required diagnosis criterion."}, {"nct_id": "NCT05996003", "eligibility": "ineligible", "reasoning": "The patient is 53 years old, which is outside the eligible age range of 4 to 14 years for this trial. Additionally, the condition is Amyotrophic Lateral Sclerosis, not Duchenne Muscular Dystrophy, and key genetic and functional criteria are not met."}, {"nct_id": "NCT06013839", "eligibility": "ineligible", "reasoning": "Patient has Amyotrophic Lateral Sclerosis, not Duchenne muscular dystrophy, which is required for eligibility. Additionally, no cardiomyopathy diagnosis or related assessments are provided."}, {"nct_id": "NCT05938023", "eligibility": "ineligible", "reasoning": "Patient is a 53-year-old male with ALS, whereas the trial requires male participants aged 10 to less than 18 years with Duchenne Muscular Dystrophy."}, {"nct_id": "NCT05185622", "eligibility": "ineligible", "reasoning": "Patient is 53 years old, which is outside the trial's age range of 2 to <18 years. Additionally, patient has Amyotrophic Lateral Sclerosis, not Duchenne Muscular Dystrophy, and the trial requires diagnosis of DMD."}, {"nct_id": "NCT06128564", "eligibility": "ineligible", "reasoning": "Patient is 53 years old and has ALS, while the trial is for males under 4 years old with Duchenne Muscular Dystrophy."}, {"nct_id": "NCT06079736", "eligibility": "ineligible", "reasoning": "The trial is for patients with Duchenne Muscular Dystrophy (DMD) amenable to exon 51 skipping, but the patient has Amyotrophic Lateral Sclerosis (ALS), a different condition."}, {"nct_id": "NCT06100887", "eligibility": "ineligible", "reasoning": "Patient is 53 years old, outside the trial age range of 6 to 14 years, and has Amyotrophic Lateral Sclerosis, not Duchenne Muscular Dystrophy."}, {"nct_id": "NCT05540860", "eligibility": "ineligible", "reasoning": "Patient is 53 years old, which is outside the eligible age range of 4 to 9 years, and has amyotrophic lateral sclerosis, not Duchenne muscular dystrophy."}, {"nct_id": "NCT05881408", "eligibility": "ineligible", "reasoning": "The trial is for Duchenne Muscular Dystrophy patients aged 8 to <18 years with specific genetic mutations, while the patient is a 53-year-old male with Amyotrophic Lateral Sclerosis and a SOD1 mutation."}, {"nct_id": "NCT05933057", "eligibility": "ineligible", "reasoning": "The trial is for male children and adolescents aged 9 to <18 years with Duchenne Muscular Dystrophy (DMD). The patient is a 53-year-old male with Amyotrophic Lateral Sclerosis (ALS), not DMD, and is outside the required age range."}, {"nct_id": "NCT04587908", "eligibility": "ineligible", "reasoning": "The trial is for patients with Duchenne Muscular Dystrophy confirmed by dystrophin genetic test, with specific mobility and weight criteria. The patient has Amyotrophic Lateral Sclerosis and a SOD1 mutation, not DMD, and does not meet any DMD-related criteria."}, {"nct_id": "NCT05126758", "eligibility": "ineligible", "reasoning": "The trial requires a diagnosis of Duchenne Muscular Dystrophy (DMD), but the patient has Amyotrophic Lateral Sclerosis (ALS), which is a different disease. Therefore, the patient does not meet the inclusion criteria."}]}, "02": {"patient_info": {"profile": {"condition": "Leukemia, Myeloid, Acute", "country": "Belgium", "age": 62, "gender": "Male", "profile": "Diagnosed with Acute Myeloid Leukemia\nMale aged 62\nHistology: 42% blasts\nPrevious treatment: 7+3 induction  and HiDAC consolidation \nBiomarkers: NPM1 mutated\nComorbidities: Depression\nOther: 5 year clean of alcohol addiction"}}, "trial_matches": [{"nct_id": "NCT06114056", "eligibility": "ineligible", "reasoning": "Patient is a 62-year-old male with Acute Myeloid Leukemia, while the trial only enrolls males aged 5 to 10 years with Duchenne Muscular Dystrophy."}, {"nct_id": "NCT06224660", "eligibility": "ineligible", "reasoning": "The patient has Acute Myeloid Leukemia, not Duchenne Muscular Dystrophy with cardiomyopathy as required by the trial. The trial specifically requires diagnosis of DMD confirmed by genetic testing."}, {"nct_id": "NCT03340675", "eligibility": "ineligible", "reasoning": "The trial is for males with Duchenne Muscular Dystrophy (DMD), but the patient has Acute Myeloid Leukemia. The conditions do not match."}, {"nct_id": "NCT05996003", "eligibility": "ineligible", "reasoning": "Patient is a 62-year-old male with acute myeloid leukemia, while the trial is only for male children aged 4 to under 15 years with Duchenne Muscular Dystrophy."}, {"nct_id": "NCT06013839", "eligibility": "ineligible", "reasoning": "Patient has Acute Myeloid Leukemia and does not have Duchenne Muscular Dystrophy or cardiomyopathy, which are required for eligibility."}, {"nct_id": "NCT05938023", "eligibility": "ineligible", "reasoning": "Patient is 62 years old, which is outside the required age range of 10 to less than 18 years, and the trial targets Duchenne Muscular Dystrophy, not Acute Myeloid Leukemia."}, {"nct_id": "NCT05185622", "eligibility": "ineligible", "reasoning": "Patient age (62 years) is outside the trial's age range (2 to <18 years) and patient has Acute Myeloid Leukemia, not Duchenne Muscular Dystrophy."}, {"nct_id": "NCT06128564", "eligibility": "ineligible", "reasoning": "Patient is 62 years old and diagnosed with acute myeloid leukemia, whereas the trial is for males under 4 years old with Duchenne Muscular Dystrophy."}, {"nct_id": "NCT06079736", "eligibility": "ineligible", "reasoning": "The trial is for patients with Duchenne Muscular Dystrophy amenable to exon 51 skipping, but the patient has Acute Myeloid Leukemia and no indication of DMD. The conditions do not match."}, {"nct_id": "NCT06100887", "eligibility": "ineligible", "reasoning": "Patient age is 62 years, which is outside the eligible age range of 6 to 14 years required for the trial."}, {"nct_id": "NCT05540860", "eligibility": "ineligible", "reasoning": "Patient is a 62-year-old male with acute myeloid leukemia, whereas the trial is for male children aged 4-9 years with Duchenne muscular dystrophy, making the patient outside the age range and disease condition required."}, {"nct_id": "NCT05881408", "eligibility": "ineligible", "reasoning": "The patient has Acute Myeloid Leukemia and does not have Duchenne Muscular Dystrophy, which is required for trial enrollment."}, {"nct_id": "NCT05933057", "eligibility": "ineligible", "reasoning": "Patient is 62 years old, which is outside the eligible age range of 9 to 17 years for the trial. Additionally, the trial is for Duchenne Muscular Dystrophy, not Acute Myeloid Leukemia."}, {"nct_id": "NCT04587908", "eligibility": "ineligible", "reasoning": "The trial is designed for patients with Duchenne Muscular Dystrophy (DMD), confirmed by dystrophin genetic test, and relates to muscle function. The patient has Acute Myeloid Leukemia, which is unrelated to DMD, and does not meet the disease criteria."}, {"nct_id": "NCT05126758", "eligibility": "ineligible", "reasoning": "The trial is specific to male subjects diagnosed with Duchenne Muscular Dystrophy (DMD), confirmed by genetic testing and clinical manifestations related to DMD. The patient has Acute Myeloid Leukemia, not DMD, and none of the inclusion criteria related to DMD diagnosis or symptoms are met."}]}, "03": {"patient_info": {"profile": {"condition": "Muscular Dystrophy, Duchenne", "country": "United Kingdom of Great Britain and Northern Ireland", "age": 6, "gender": "Male", "profile": "Histology: None\nPrevious treatment: Deflazacort\nBiomarkers: DMD exon 27 deletion\nTests: LVEF 62%, eGFR 92 ml/min/1.73m2\nComorbidities: None\nOther: Ambulatory"}}, "trial_matches": [{"nct_id": "NCT06114056", "eligibility": "eligible", "reasoning": "Patient is a 6-year-old male with DMD confirmed by genetic testing (DMD exon 27 deletion within exons 18-58), on stable corticosteroid treatment (Deflazacort), ambulatory, with normal LVEF (62%) and eGFR, no comorbidities or contraindications listed. No evidence of exclusion criteria present."}, {"nct_id": "NCT06224660", "eligibility": "ineligible", "reasoning": "Patient is 6 years old but trial requires age from 18 years; no evidence of cardiomyopathy or left ventricular ejection fraction below 40%."}, {"nct_id": "NCT03340675", "eligibility": "ineligible", "reasoning": "Patient is 6 years old, but the trial requires a minimum age of 7 years."}, {"nct_id": "NCT05996003", "eligibility": "ineligible", "reasoning": "Patient has a confirmed DMD exon 27 deletion, but the trial requires a mutation amenable to skipping of exon 44 to restore the reading frame."}, {"nct_id": "NCT06013839", "eligibility": "ineligible", "reasoning": "Patient is 6 years old, but trial requires males 16 years or older and non-ambulant status; patient is ambulatory."}, {"nct_id": "NCT05938023", "eligibility": "ineligible", "reasoning": "Patient is only 6 years old and the trial requires male participants aged 10 to less than 18 years. Additionally, the patient is ambulatory, but the trial requires non-ambulatory participants."}, {"nct_id": "NCT05185622", "eligibility": "eligible", "reasoning": "Patient is a 6 year old male with a confirmed DMD gene deletion (exon 27), fits within the age range (2 to <4 or 7 to <18), male, ambulatory, stable glucocorticoid use (Deflazacort reported, presumed stable), no comorbidities or exclusions listed, normal lab values (LVEF and eGFR normal), no contraindications stated; assumptions made that other criteria like varicella immunity and lab values are met or not clinically significant."}, {"nct_id": "NCT06128564", "eligibility": "ineligible", "reasoning": "Patient age is 6 years old, which is outside the trial age limit of under 4 years."}, {"nct_id": "NCT06079736", "eligibility": "ineligible", "reasoning": "Patient is 6 years old, but the trial requires a minimum age of 8 years at consent."}, {"nct_id": "NCT06100887", "eligibility": "ineligible", "reasoning": "Patient has not received prior AAV-based gene therapy, which is a key inclusion criterion for the trial."}, {"nct_id": "NCT05540860", "eligibility": "uncertain", "reasoning": "Patient meets key criteria of age, gender, diagnosis, DMD gene mutation, corticosteroid use, and cardiac function. However, insufficient information on patient's ability to complete stand from supine and 4-stair climb within required times, and body weight data is missing."}, {"nct_id": "NCT05881408", "eligibility": "ineligible", "reasoning": "Patient is ambulatory but is only 6 years old; trial requires ambulatory subjects to be \u22658 to <18 years old. Additionally, the patient's DMD mutation is an exon 27 deletion, which likely is an in-frame deletion and not a pathogenic frameshift or premature stop codon mutation between exons 18 and 79, as required."}, {"nct_id": "NCT05933057", "eligibility": "ineligible", "reasoning": "The patient is ambulatory, but the trial requires non-ambulant patients. Additionally, the patient's age (6 years) is below the eligibility range of 9 to <18 years."}, {"nct_id": "NCT04587908", "eligibility": "eligible", "reasoning": "Patient is a 6-year-old male with genetically confirmed DMD, ambulatory, and meets the age and weight criteria. LVEF is 62% (above the 40% cutoff). No recent injuries, no reported use of COX inhibitors or NSAIDs in last 7 days, no prior gene or cell therapy mentioned, no comorbidities or severe cardiac or respiratory diseases, and stable on Deflazacort. No contraindications noted."}, {"nct_id": "NCT05126758", "eligibility": "ineligible", "reasoning": "The patient is 6 years old, but the inclusion criteria require males to be at least 10 years old at time of consent."}]}}